{"id":"W2808572932","doi":"10.3747/co.25.3750","title":"Current Landscape of Immunotherapy for the Treatment of Metastatic Non-Small-Cell Lung Cancer","year":2018,"lang":"en","type":"review","venue":"Current Oncology","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":45,"is_retracted":false,"has_abstract":true,"ca_institutions":"","funders":"Peking University; Peking University People's Hospital; National Natural Science Foundation of China","keywords":"Pembrolizumab; Atezolizumab; Medicine; Nivolumab; Immunotherapy; Lung cancer; Oncology; Chemotherapy; Internal medicine; Clinical trial; Cancer","routes":{"ca_aff":false,"ca_fund":false,"ca_venue":true,"about_ca":false,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007900922,0.000754107,0.001161809,0.002151885,0.0002600466,0.0008871433,0.000869633,0.001010709,0.003957766],"category_scores_gemma":[0.0009052481,0.000229,0.0005945626,0.002081843,0.000374534,0.001449211,0.0006209592,0.001853564,0.001809165],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0005381079,"about_ca_system_score_gemma":0.001213955,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0007880357,"about_ca_topic_score_gemma":0.00156383,"domain_scores_codex":[0.9997273,0.00005483007,0.00004966558,0.00003776468,0.0001099353,0.0000205167],"domain_scores_gemma":[0.9995739,0.000211748,0.00007009069,0.00001200538,0.0001023596,0.00002995263],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.00004422918,0.0000496953,0.0001012495,0.02378511,0.00007982388,0.00008754205,0.00005113402,0.0002295163,0.0009264383,0.002384363,0.02199439,0.9502665],"study_design_scores_gemma":[0.00001832128,0.00008440954,0.0006374387,0.00784431,0.0001466916,0.0007913456,0.00005772707,0.00006384248,0.0002180779,0.001938477,0.988186,0.0000133601],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.00005809715,0.9988403,0.00006397271,0.0003168509,0.00011184,0.000005488577,0.00001214317,0.000004852447,0.0005864634],"genre_scores_gemma":[0.0003054214,0.999034,0.0001189643,0.0001926206,0.00009380472,0.000006199011,0.00001708793,8.802823e-7,0.0002309182],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.003957766,"threshold_uncertainty_score":0.0132401,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1612086509722732,"score_gpt":0.4704134536338138,"score_spread":0.3092048026615407,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}